With the analysis among 451 patents, we discovered top 135 key players by total patent application. Cogent Biosciences, Inc., Serum Institute of India Pvt Ltd., VentiRx Pharmaceuticals, Inc. are dominant in this area. They take 12.86% of the total patent filing.
Massachusetts, United States
Patent: 25
Serum Institute of India Pvt Ltd.
Maharashtra, India
Patent: 17
VentiRx Pharmaceuticals, Inc.
Washington, United States
Patent: 15
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 14
ZURICH, Switzerland
Patent: 14
Baden-Württemberg, Germany
Patent: 14
Lexigen Pharmaceuticals Corp.
Massachusetts, United States
Patent: 14
California, United States
Patent: 11
Outlook Therapeutics, Inc.
New Jersey, United States
Patent: 10
Hessen, Germany
Patent: 10
With the analysis among 13 patents, we discovered top 6 start-ups by total patent application. Indapta Therapeutics, Inc., LFB USA, Inc., IO Biotech ApS are active in this area.
Indapta Therapeutics, Inc.
California, United States
Patent: 6
Massachusetts, United States
Patent: 2
Hovedstaden, Denmark
Patent: 2
Hangzhou Deep Informatics Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 1
Bondwell Technologies, Inc.
Texas, United States
Patent: 1
With the analysis among related 177 patents applied in the last 5 years. We discover 81 most active companies in this area. The fast-growing Cogent Biosciences, Inc., Shenzhou Cell Engineering Co Ltd., Kyowa Kirin Co., Ltd. take 16.95% of patent filing during this period.
Massachusetts, United States
Patent: 14
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 9
New York, United States
Patent: 7
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 7
NOTTINGHAM, United Kingdom
Patent: 7
Kagoshima-ken, Japan
Patent: 7
Oost-Vlaanderen, Belgium
Patent: 6
Indapta Therapeutics, Inc.
California, United States
Patent: 6
With the analysis among related 177 patents in last 5 years, we discover 60 new entrants. Shenzhou Cell Engineering Co Ltd., Bristol Myers Squibb Co., Dana-Farber Cancer Institute, Inc. are the most active new entrants in this area.
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 9
New York, United States
Patent: 7
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 7
NOTTINGHAM, United Kingdom
Patent: 7
Kagoshima-ken, Japan
Patent: 7
Oost-Vlaanderen, Belgium
Patent: 6
Indapta Therapeutics, Inc.
California, United States
Patent: 6
Gemini Therapeutics Sub, Inc.
Massachusetts, United States
Patent: 4
Yonsei Industry-Academic Cooperation Foundation
With the analysis among 185 patents, we discovered top 33 universities and scientific research institutions by total patent application. The Rockefeller University, National University of Singapore, The University of North Carolina at Chapel Hill are dominant in this area. They take 27.57% of the total patent filing.
The Rockefeller University
New York, United States
Patent: 11
National University of Singapore
Central Region, Singapore
Patent: 7
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 7
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 7
Kagoshima-ken, Japan
Patent: 7
Hovedstaden, Denmark
Patent: 6
Oost-Vlaanderen, Belgium
Patent: 6
Tennessee, United States
Patent: 4
Technical University of Denmark
Hovedstaden, Denmark
Patent: 4
President & Fellows of Harvard College
Massachusetts, United States
Patent: 4